A synthetic peptide for use as a blocking control in assays to test for specificity of EML1 antibody, Alternative Names: EML1 control peptide, EML1 antibody Blocking Peptide, Anti-EML1 Blocking Peptide, Echinoderm Microtubule Associated Protein Like 1 Blocking Peptide, ELP79 Blocking Peptide, EMAP Blocking Peptide, EMAPL Blocking Peptide, FLJ45033 Blocking Peptide, HuEMAP Blocking Peptide, EML1, EML-1, EML 1, EML-1 Blocking Peptide, EML 1 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
EML1
(Echinoderm Microtubule Associated Protein Like 1 (EML1))
Hintergrund
Human echinoderm microtubule-associated protein-like is a strong candidate for the Usher syndrome type 1A gene. Usher syndromes (USHs) are a group of genetic disorders consisting of congenital deafness, retinitis pigmentosa, and vestibular dysfunction of variable onset and severity depending on the genetic type.